Evidence map›Paper›PMID 36552548›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL.

Domenico Sergi, Enrico Zauli, Fabio Casciano, Paola Secchiero, Giorgio Zauli, Matteo Fields, Elisabetta Melloni

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Domenico SergiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-3001-410X
Enrico ZauliDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Fabio CascianoDepartment of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-6431-3335
Paola SecchieroDepartment of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
Giorgio ZauliKing Khaled Eye Specialistic Hospital, Riyadh 11462, Saudi Arabia.
Matteo FieldsDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Elisabetta MelloniDepartment of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-7829-0824
University of Ferrara · ITKing Khaled Eye Specialist Hospital · SA

Funding

University of Ferrara FAR and FIRD
6 · The paper itself

Abstract

Hyperglycaemia and increased circulating saturated fatty acids are key metabolic features of type 2 diabetes mellitus (T2DM) that contribute to diabetic retinopathy pathogenesis. Contrarily, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has been shown to improve or prevent T2DM. This study aimed at investigating the effect of TRAIL in an in vitro model of human retinal pigment epithelium: the ARPE-19 cell line, treated with palmitic acid (PA) in the presence of high glucose concentration. PA caused a drop in cellular metabolic activity and cell viability as well as an increase in apoptosis rates, which were paralleled by an upregulation of reactive oxygen species (ROS) generation as well as mitochondrial fragmentation. Despite ARPE-19 cells expressing TRAIL-R2 at the cell surface, TRAIL failed to counteract the cytotoxic effects of PA. However, when TRAIL was used alongside PA and then removed or used alone following PA challenge, it partially attenuated PA-induced lipotoxicity. This effect of TRAIL appeared to rely upon the modulation of inflammation and ROS production. Thus, TRAIL exerted a trophic effect on ARPE-19 cells, which became evident only when the lipotoxic insult was removed. Nevertheless, whether recombinant TRAIL might have a therapeutic potential for the treatment of diabetic retinopathy requires further investigation.

Indexed as

ARPE-19lipotoxicitypalmitic acidretinal pigment epithelial cellsTRAILtype 2 diabetes mellitus

Identifiers

PMID36552548
PMCPMC9774631
OpenAlexW4310211637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.